347 results on '"Sorgho, Hermann"'
Search Results
2. The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial
3. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study
4. Performance of PfHRP2-RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso
5. Genome-wide association study meta-analysis of blood pressure traits and hypertension in sub-Saharan African populations: an AWI-Gen study
6. Prostration and the prognosis of death in African children with severe malaria
7. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
8. Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients
9. Obesity phenotypes and dyslipidemia in adults from four African countries: An H3Africa AWI-Gen study.
10. Author Correction: Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits
11. Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
12. Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits
13. Genetic associations with carotid intima-media thickness link to atherosclerosis with sex-specific effects in sub-Saharan Africans
14. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
15. Effects of gestational age on blood cortisol and prolactin levels during pregnancy in malaria endemic area.
16. Correction: Performance of PfHRP2‑RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso
17. Genetic association and transferability for urinary albumin-creatinine ratio as a marker of kidney disease in four Sub-Saharan African populations and non-continental individuals of African ancestry
18. Kidney damage and associated risk factors in rural and urban sub-Saharan Africa (AWI-Gen): a cross-sectional population study
19. Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial
20. Expanding the human gut microbiome atlas of Africa
21. Prevalence and determinants of anaemia among pregnant women in a high malaria transmission setting: a cross-sectional study in rural Burkina Faso
22. Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
23. Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density
24. Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
25. Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
26. Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life
27. OA-58 Associations between prenatal malaria exposure, maternal antibodies at birth and malaria susceptibility during the first year of life in Burkina Faso
28. PA-730 Impact of additional screening using highly-sensitive rapid diagnostic tests and treatment combined with monthly Sulfadoxine-Pyrimethamine on LBW and peripheral malaria infection: asser malaria study
29. PA-216 Contribution of next generation sequencing (NGS) tools for molecular surveillance of malaria drug resistance markers in Burkina Faso
30. Regional and Sex Differences in the Prevalence and Awareness of Hypertension: An H3Africa AWI-Gen Study Across 6 Sites in Sub-Saharan Africa
31. Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
32. Regional Patterns and Association Between Obesity and Hypertension in Africa: Evidence From the H3Africa CHAIR Study
33. Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
34. Undernutrition in children aged 0–59 months by region and over time: secondary analysis of the Burkina Faso 2012–2018 National Nutrition Surveys
35. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey
36. In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
37. Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
38. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
39. Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
40. Immunomodulatory effects of gestational age on blood cortisol and prolactin levels during pregnancy in malaria endemic area
41. Diabetes care cascade and associated factors in 10 700 middle-aged adults in four sub-Saharan African countries: a cross-sectional study
42. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
43. Investing in human development and building state resilience in fragile contexts: a case study of early nutrition investments in Burkina Faso
44. Identifying the prevalence and correlates of multimorbidity in middle-aged men and women: a cross-sectional population-based study in four African countries
45. Genome-wide Association Study Meta-analysis of Blood Pressure Traits and Hypertension in Sub-Saharan African Populations: An AWI-Gen Study
46. Men’s motivations, barriers to and aspirations for their families’ health in the first 1000 days in sub-Saharan Africa: a secondary qualitative analysis
47. The Public Health Impact and Cost-Effectiveness of the R21/Matrix-M Malaria Vaccine: A Mathematical Modelling Study
48. What works in engaging communities? Prioritising nutrition interventions in Burkina Faso, Ghana and South Africa.
49. Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life
50. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.